Yennurajalingam, Sriram
Thomas, Lisa
Stanton, Penny A.
Lu, Zhanni
de Moraes, Aline Rozman
Bruera, Eduardo
Article History
Received: 8 January 2024
Accepted: 10 June 2024
First Online: 25 June 2024
Declarations
: During the preparation of this work the authors have not used any AI or AI-assisted technologies.
: The University of Texas MD Anderson Cancer Center Institutional Review Board approved the protocol in accordance with the Declaration of Helsinki, and all patients were provided written informed consent for participation of the study.
: Sriram Yennurajalingam, Pfizer (research funding for Cachexia study); Pfizer (Consultation for Cachexia study). The rest of the authors declare no conflict of interest.